56 -5 (67) 2024 - A.A. Madaliev, D.A.Nishanov - BACKGROUND INFLAMMATORY BOWEL DISEASES THAT INCREASE THE RISK OF COLORECTAL CANCER: THEIR COMMON FEATURES AND DIFFERENCES, MORPHOLOGICAL SUBSTRATE

BACKGROUND INFLAMMATORY BOWEL DISEASES THAT INCREASE THE RISK OF COLORECTAL CANCER: THEIR COMMON FEATURES AND DIFFERENCES, MORPHOLOGICAL SUBSTRATE

A.A. Madaliev - Republican Specialized Scientific and Practical Medical Center of Oncology and Radiology “RSNPMTsOiR” of the Republic of Uzbekistan

D.A.Nishanov - Republican Specialized Scientific and Practical Medical Center of Oncology and Radiology “RSNPMTsOiR” of the Republic of Uzbekistan

M.H.Umarov - Republican Specialized Scientific and Practical Medical Center of Oncology and Radiology “RSNPMTsOiR” of the Republic of Uzbekistan

A.U.Amriddinov - Kashkadarya regional branch of RSNPMTSOIR

Resume

IBD is a group of idiopathic inflammatory bowel diseases, the main components of which are Crohn's disease (CD) and ulcerative colitis (UC), each of which has independent clinical and pathomorphological manifestations. The pathogenesis of the chin has not been fully studied. Genetic and environmental factors, such as changes in intestinal bacteria and increased intestinal permeability, play a role in regulating the intestinal immune response, which leads to damage to the stomach and intestines. This study examined various components of the disease among patients with inflammatory bowel disease based on retrospective material.

Keywords: inflammatory bowel diseases, Crohn's disease, ulcerative colitis, histology, pseudopolyp, Immunology.

First page

330

Last page

333

For citation: A.A. Madaliev, D.A.Nishanov, M.H.Umarov, A.U.Amriddinov - BACKGROUND INFLAMMATORY BOWEL DISEASES THAT INCREASE THE RISK OF COLORECTAL CANCER: THEIR COMMON FEATURES AND DIFFERENCES, MORPHOLOGICAL SUBSTRATE//New Day in Medicine 5(67)2024 330-333 https://newdayworldmedicine.com/en/article/3758

List of References

1. Molodecky NA, Soon I.S., Rabi D.M., Ghali W.A., Ferris M, Chernoff G, et al. Increasing incidence and prevalence of the inflammatory bowel diseases with time, based on systematic review. // Gastroenterology 2020; 46-54.
2. Magro F., Gionchetti P.P., Eliakim R. et al. Third European Evidence-based Consensus on Diagnosis and Management of Ulcerative Colitis. Journal of Crohn's & Colitis. 2021; 650.
3. Li S., Konstantinov S.R., Smits R., Peppelenbosch M.P. Bacterial biofilms in colorectal cancer initiation and progression // Trends Mol Med. – 2022; 18-30.
4. Ivashkin V.T., Shelygin Yu.A., Khalif I.L. и соавт. Diagnosis and treatment of the irritable bowel syndrome: clinical guidelines of the Russian gastroenterological association and Russian association of coloproctology. 2019; 9-10.
5. Dzutsev A., Goldszmid R.S., Viaud S. et al. The role of the microbiota in inflammation, carcinogenesis, and cancer therapy // Eur. J. Immunol. – 2021; 17.

   file

   download